Skip to main content
Journal ArticleOPEN ACCESS

Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb ® )—A case report

  • Moresco E
  • Rugg C
  • Ströhle M
  • et al.
Clinical Case Reports (2022) 10(1)
DOI: 10.1002/ccr3.5272
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb ® ) might increase its efficacy.

Cite

CITATION STYLE

APA

Moresco, E., Rugg, C., Ströhle, M., & Thoma, M. (2022). Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb ® )—A case report. Clinical Case Reports, 10(1). https://doi.org/10.1002/ccr3.5272

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free